Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis

  • ID: 2634732
  • Report
  • Region: Global
  • Lucintel
1 of 3
The global pharmaceutical industry revenue is forecasted to reach an estimated $1,226.0 billion by 2018, with good growth over the next five years (2013-2018). The industry is expected to register growth led by aging population, changing lifestyles, hectic daily activities, unhealthy eating habits, increasing incidence of chronic diseases across the entire global population providing growth opportunities for the industry players.

The industry is engaged in discovery, development, manufacture, and marketing of prescription drugs. Industry products include ethical drugs and consumer healthcare but animal healthcare drugs are not included.

The global pharmaceutical market faces major challenge from increasing investment and strict regulation. Changing lifestyles and the fast socio-demographic shift due to urbanization in both developed and growth markets globally are expected drive the demand. The ability to create new technology and innovative drugs is a key driver for success in this market.

North America is projected to lead the pharmaceutical industry. Vaccine industry is expected to record the highest growth during the forecast period. ROW industry is expected to witness the highest growth during 2013-2018. Government initiatives in Brazil to encourage drugs industries by providing free pricing policies and special financial investment options will attract the industry players. APAC holds good growth potential for the future.

This study provides an overview of the global pharmaceutical industry by tracking 13 market segments of that industry in four geographic regions. Thus, a total of 52 segments of the global pharmaceutical industry are tracked. The report studies manufacturers of bone, respiratory, immunology and dermatology, cardiovascular, diabetes & obesity, urinary/kidney diseases, gastrointestinal, neurosciences, infectious diseases, ophthalmology, oncology, women’s health/ endocrine, vaccines, consumer health/OTC, and others providing a five-year (2007-2012) annual trend analysis that highlights market size, profit and cost structure for NA, Europe, APAC, and ROW. The report also provides a forecast, addressing market opportunities for next five years (2013-2018) for each of these regions.

This comprehensive guide provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global pharmaceutical industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.

Features and Scope of this Report:
To make any investment or strategic decision, you need adequate and timely information. This market report fulfils this core need. Some of the features of this market report are:

- Industry size estimates in terms of (US $) value by regions and by segments
- Global pharmaceutical industry annual trend (2007-2012) and forecast (2013-2018)
- Porter’s Five Force analysis
- New product launch, merger and acquisition activity in global pharmaceutical industry
- Quarterly demand trend (Q1 2011-Q4 2012) and forecast analysis (Q1 2013-Q4 2014) for pharmaceutical industry analysis
- Gross and net profit trends in the global pharmaceutical industry
- Cost structure trend in the global as well as regional pharmaceutical industry

The report is in PowerPoint format and has hundreds of critical data and market insights that will help in effective decision-making.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Executive Summary
2. Industry Definition and Scope
3. Industry Overview
4. Macroeconomic Trend
5. Industry Trends
6. Competitive Landscape
7. Macroeconomic Forecast
8. Industry Forecasts
9. Emerging Trends
10. Unmet Needs
11. Growth Opportunity
12. Conclusions

List of Figures

Chapter 3. Industry Overview
Figure 3.1: External forces shaping global pharmaceutical industry

Chapter 4. Global Macroeconomic Overview
Figure 4.1: Global GDP growth rate trend
Figure 4.2: Global inflation rate trend
Figure 4.3: Global population growth rate trend
Figure 4.4: Global unemployment rate trend
Figure 4.5: Regional GDP growth rate trend
Figure 4.6: Regional inflation rate trend
Figure 4.7: Regional population growth rate trend
Figure 4.8: Regional unemployment rate trend

Chapter 5. Industry Trends
Figure 5.1: Global pharmaceutical industry annual trend 2007-2012 ($B)
Figure 5.2: Global pharmaceutical industry regional trend 2007-2012 ($B)
Figure 5.3: Global pharmaceutical industry regional trend 2007-2012 (%)
Figure 5.4: Global pharmaceutical industry segment trend 2007-2012 ($B)
Figure 5.5: Global pharmaceutical industry segment trend 2007-2012 (%)
Figure 5.6: Global pharmaceutical industry quarterly trend 2011-2012 ($B)
Figure 5.7: Global pharmaceutical industry profitability trend 2007-12
Figure 5.8: Global pharmaceutical industry revenue per employee trend 2007-12
Figure 5.9: Cost structure of global pharmaceutical industry 2007-12
Figure 5.10: Cost structure in North American pharmaceutical industry 2007-12
Figure 5.11: Cost structure in European pharmaceutical industry 2007-12
Figure 5.12: Cost structure in Asia Pacific pharmaceutical industry 2007-12
Figure 5.13: Top 5 companies vs. pharmaceutical industry gross profit & net profit analysis 2012
Figure 5.14: Cash on hand for global pharmaceutical industry 2007-12 (US $B)
Figure 5.15: Cash on hand for global pharmaceutical industry 2007-12 (%)
Figure 5.16: Asset for global pharmaceutical industry 2007-12 (US $B)
Figure 5.17: Assets for global pharmaceutical industry 2007-12 (%)
Figure 5.18: Debt for global pharmaceutical industry 2007-12 (US $B)
Figure 5.19: Debt for global pharmaceutical industry 2007-12 (%)
Figure 5.20: Industry shares of top players in global pharmaceutical industry in 2007
Figure 5.21: Industry shares of top players in global pharmaceutical industry in 2012
Figure 5.22: Global pharmaceutical industry 2007 market share analysis
Figure 5.23: Global pharmaceutical industry 2012 market share analysis

Chapter 6. Competitive Landscape
Figure 6.1: Market shares of top players in global pharmaceutical industry in 2007
Figure 6.2: Market shares of top players in global pharmaceutical industry in 2012
Figure 6.3: Global pharmaceutical industry 2007 market share analysis
Figure 6.4: Global pharmaceutical industry 2012 market share analysis
Figure 6.5: Top five companies v/s pharmaceuticalindustry gross profit & net profit analysis 2012

Chapter 7. Macroeconomic Forecast
Figure 7.1: Global GDP growth rate forecast
Figure 7.2: Global population growth rate forecast
Figure 7.3: Global inflation rate forecast
Figure 7.4: Global unemployment rate forecast
Figure 7.5: Regional GDP growth rate forecast at constant price
Figure 7.6: Regional population growth rate forecast
Figure 7.7: Regional inflation rate forecast
Figure 7.8: Regional unemployment rate forecast

Chapter 8. Industry Forecasts
Figure 8.1: Global pharmaceutical industry annual forecast 2013-2018 ($B)
Figure 8.2: Global pharmaceutical industry quarterly forecast 2013-2014 ($B
Figure 8.3: Global pharmaceutical industry regional forecast 2013-2018 ($B)
Figure 8.4: Global pharmaceutical industry regional forecast 2013-2018 (%)
Figure 8.5: Global pharmaceutical industry segment forecast 2013-2018 ($B)
Figure 8.6: Global pharmaceutical industry segment forecast 2013-2018 (%)
Figure 8.7: Regional population trend on the basis of age 2012
Figure 8.8: Regional population trend on the basis of age 2018

Chapter 9. Emerging Trends
Figure 9.1: Emerging trends in global pharmaceutical industry

Chapter 10. Unmet Needs
Figure 10.1 Emerging trends in global pharmaceuticalindustry

Chapter 11. Growth Opportunity
Figure 11.1: Global pharmaceutical industry opportunity by region

List of Tables

Chapter 3. Industry Overview
Table 3.1: Industry parameters of global pharmaceutical industry
Table 3.2: Relative industry attractiveness by region

Chapter 5. Industry Trends
Table 5.1: Regional revenue growth rate
Table 5.2: Segment revenue growth rate
Table 5.3: Percentage change in cost structure
Table 5.4: Percentage change in cash on hand
Table 5.5: Percentage change in total asset
Table 5.6: Percentage change in total debt
Table 5.7: Key companies by revenue growth
Table 5.7: Key companies by high revenue growth
Table 5.8: Key companies by low revenue growth

Chapter 8. Industry Forecasts
Table 8.1: Global pharmaceutical regional forecast growth rate
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll